Study analysis · Pharmaceuticals · 2026
This omega-3 drink crushed inflammation by 95%—but only in a petri dish.
Two omega-3 drinks silenced angry immune cells in a lab, with one cutting a key inflammation chemical by 95%.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study tested two omega-3 supplements in a dish with immune cells from one person. It showed the supplements made the cells less reactive to a bacterial trigger. But it didn't test this in real people or in the body, so we can't say it will work the same way in humans.
What’s the bottom line?
Scientists tested two omega-3 drink formulas on human immune cells in a dish, after making them angry with a bacterial trigger.
How strong is this study?
The experiment was done carefully in the lab, but using cells from just one person makes it like testing a new toy on one kid—you don't know if it'll work for everyone else. That's why we need more tests with more people before we trust it for real health advice.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
31 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1)+0.1/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an in vitro study using monocytes from a single donor, with no randomization, control group beyond LPS stimulation, or replication across individuals. It cannot establish causation in humans or rule out confounding factors.
Major COI
Major conflicts that significantly reduce study credibility
The study was conducted by authors affiliated with VivaCell Biotechnology GmbH, a company that likely produces the Omega-3-based nutraceuticals under investigation, creating a significant conflict of interest.
Funders
Conflict Details
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
Ethno-Health Group B.V.: Affiliated with a company potentially involved in the nutraceutical supply chain
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
No independent funding source or external oversight is mentioned. The entire research team is employed by entities with direct commercial interest in the product tested, raising serious concerns about bias in study design, data interpretation, and publication.
Key takeaways
- 01
One drink cut the angry chemical PGE2 by 95%, the other by 80%.
- 02
Both cut other angry signals (TNF-α, IL-1β, IL-6) by up to 70%, but didn't touch IL-8 much.
- 03
Cells stayed alive and didn't make calming signals.
- 04
This means these drinks might help reduce inflammation in the body by silencing key troublemakers — but only in a lab dish, not yet proven in people.
Surprising findings
- Omega 3 Orange suppressed PGE2 by 95%, far more than any other cytokine.Most omega-3 studies show modest effects on cytokines, but this level of PGE2 suppression rivals pharmaceutical COX-2 inhibitors—yet it’s from a drinkable supplement.
- IL-8 was barely affected, even at the highest dose.IL-8 is a major inflammatory chemokine, and most anti-inflammatories blunt it. The fact that these formulations ignored it suggests a highly targeted mechanism.
- No IL-10 was induced—meaning no anti-inflammatory feedback loop was activated.People assume natural anti-inflammatories work by boosting 'good' signals like IL-10. This study shows they might just silence 'bad' ones instead.
Practical takeaways
If you're looking for natural inflammation support, consider omega-3 supplements with DHA/EPA + curcumin (like these formulations)—they may target PGE2 more effectively than plain fish oil.
This was tested in a dish, not in your body. Doses used (up to 2.5%) are far higher than what you’d get from a typical supplement pill.
low confidenceAvoid assuming all omega-3s are equal—this study suggests formulation matters. Look for blends with algae oil, curcumin, or other synergistic ingredients.
No human data exists yet. Don’t replace prescribed anti-inflammatories without consulting a doctor.
low confidenceUse this as a conversation starter with your doctor: 'I read about a study where a supplement suppressed PGE2 by 95%—could this be relevant for my joint pain or arthritis?'
This is not medical advice. The study is preliminary and not a substitute for clinical treatment.
low confidenceWhy this study matters
95% PGE2 Suppression? That’s Wild.
Omega 3 Orange reduced prostaglandin E2 (PGE2)—a major inflammation and pain driver—by 95% at the highest dose in human monocytes. Omega 3 Plus cut it by 80%. Both also slashed TNF-α, IL-1β, and IL-6 by up to 70%.
PGE2 is the same molecule targeted by NSAIDs like ibuprofen—but these drinks did it without pills, and with no cell death. That’s a huge deal for people seeking natural alternatives.
It Didn’t Touch IL-8—That’s a Feature, Not a Bug.
Despite suppressing most inflammatory signals, neither formulation significantly reduced IL-8—a chemokine that recruits neutrophils to fight infection. This suggests selective targeting, not broad immune suppression.
Most supplements shut down everything. This one seems to quietly disable the 'fire' without disabling the 'firefighters.' That’s smarter than typical anti-inflammatories.
No IL-10 Boost? That’s Unexpected.
Neither supplement triggered the anti-inflammatory cytokine IL-10, meaning they didn’t activate the body’s natural calming system—they just turned down the noise.
Most people assume anti-inflammatory foods 'calm' the immune system by boosting good signals. This study says: nope, they just mute the bad ones.
One Donor. One Lab. One Big Caveat.
All experiments used monocytes from a single healthy donor. No animal or human trials. No comparison to drugs like aspirin or fish oil. The results are promising—but not proven in real bodies.
This isn’t a miracle cure—it’s a lab curiosity. But it’s a *very* loud curiosity that deserves follow-up.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists tested two omega-3 drink formulas on human immune cells in a dish, after making them angry with a bacterial trigger.
Research results
One drink cut the angry chemical PGE2 by 95%, the other by 80%. Both cut other angry signals (TNF-α, IL-1β, IL-6) by up to 70%, but didn't touch IL-8 much. Cells stayed alive and didn't make calming signals.
What this means - more context
This means these drinks might help reduce inflammation in the body by silencing key troublemakers — but only in a lab dish, not yet proven in people.
This study evaluates whether two omega-3-based nutraceutical formulations, Omega 3 Plus and Omega 3 Orange, suppress LPS-induced inflammation in primary human monocytes.
Both formulations significantly reduced pro-inflammatory mediators (TNF-α, IL-1β, IL-6, MCP-1, PGE2) in a dose-dependent manner in LPS-stimulated human monocytes, with Omega 3 Orange inhibiting PGE2 by ~95% and Omega 3 Plus by ~80%. Neither affected IL-8 substantially or induced IL-10. No cytotoxicity was observed up to 2.5% concentration.
Methods Used
Primary human monocytes from a single healthy donor were isolated and stimulated with LPS (10 ng/mL) for 24 hours after pre-treatment with Omega 3 Plus or Omega 3 Orange (0.001–2.5%). Cell viability was assessed via AlamarBlue assay; inflammatory mediators (TNF-α, IL-1β, IL-6, MCP-1, IL-8, PGE2, IL-10) were quantified using ELISA. Statistical analysis used one-way ANOVA with Dunnett’s post hoc test.
Main Finding
Omega 3 Orange reduced LPS-induced PGE2 by ~95% and key cytokines (TNF-α, IL-1β, IL-6) by up to ~70%; Omega 3 Plus reduced PGE2 by ~80% and cytokines by up to ~70%, with minimal effect on IL-8 and no induction of IL-10, indicating selective, non-cytotoxic suppression of pro-inflammatory mediators.
Confidence Level
Low to moderate — findings are robust within the experimental model but limited by use of monocytes from a single donor, no pharmacological comparator, and lack of in vivo validation or mechanistic probing.
Study Flags
Red Flags
- •Single donor used for all experiments
- •No in vivo or clinical validation
- •No comparison to standard anti-inflammatory drugs
Surprising Findings
Omega 3 Orange suppressed PGE2 by 95%, far more than any other cytokine.
Most omega-3 studies show modest effects on cytokines, but this level of PGE2 suppression rivals pharmaceutical COX-2 inhibitors—yet it’s from a drinkable supplement.
Practical Takeaways
If you're looking for natural inflammation support, consider omega-3 supplements with DHA/EPA + curcumin (like these formulations)—they may target PGE2 more effectively than plain fish oil.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study tested two omega-3 supplements in a dish with immune cells from one person. It showed the supplements made the cells less reactive to a bacterial trigger. But it didn't test this in real people or in the body, so we can't say it will work the same way in humans.
Major conflicts — industry funding with significant control over the research. Reporting score and overall score cap have been reduced.
Strengths
- Used primary human monocytes (not cell lines)
- Standardized LPS stimulation protocol
- Dose-response testing across multiple concentrations
Weaknesses
- Single donor limits generalizability
- No randomization or blinding
- No control group beyond LPS (e.g., positive pharmacological control)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists tested two omega-3 drink formulas on human immune cells in a dish, after making them angry with a bacterial trigger.
Research results
One drink cut the angry chemical PGE2 by 95%, the other by 80%. Both cut other angry signals (TNF-α, IL-1β, IL-6) by up to 70%, but didn't touch IL-8 much. Cells stayed alive and didn't make calming signals.
What this means - more context
This means these drinks might help reduce inflammation in the body by silencing key troublemakers — but only in a lab dish, not yet proven in people.
This study evaluates whether two omega-3-based nutraceutical formulations, Omega 3 Plus and Omega 3 Orange, suppress LPS-induced inflammation in primary human monocytes.
Both formulations significantly reduced pro-inflammatory mediators (TNF-α, IL-1β, IL-6, MCP-1, PGE2) in a dose-dependent manner in LPS-stimulated human monocytes, with Omega 3 Orange inhibiting PGE2 by ~95% and Omega 3 Plus by ~80%. Neither affected IL-8 substantially or induced IL-10. No cytotoxicity was observed up to 2.5% concentration.
Methods Used
Primary human monocytes from a single healthy donor were isolated and stimulated with LPS (10 ng/mL) for 24 hours after pre-treatment with Omega 3 Plus or Omega 3 Orange (0.001–2.5%). Cell viability was assessed via AlamarBlue assay; inflammatory mediators (TNF-α, IL-1β, IL-6, MCP-1, IL-8, PGE2, IL-10) were quantified using ELISA. Statistical analysis used one-way ANOVA with Dunnett’s post hoc test.
Main Finding
Omega 3 Orange reduced LPS-induced PGE2 by ~95% and key cytokines (TNF-α, IL-1β, IL-6) by up to ~70%; Omega 3 Plus reduced PGE2 by ~80% and cytokines by up to ~70%, with minimal effect on IL-8 and no induction of IL-10, indicating selective, non-cytotoxic suppression of pro-inflammatory mediators.
Confidence Level
Low to moderate — findings are robust within the experimental model but limited by use of monocytes from a single donor, no pharmacological comparator, and lack of in vivo validation or mechanistic probing.
Study Flags
Red Flags
- •Single donor used for all experiments
- •No in vivo or clinical validation
- •No comparison to standard anti-inflammatory drugs
Surprising Findings
Omega 3 Orange suppressed PGE2 by 95%, far more than any other cytokine.
Most omega-3 studies show modest effects on cytokines, but this level of PGE2 suppression rivals pharmaceutical COX-2 inhibitors—yet it’s from a drinkable supplement.
Practical Takeaways
If you're looking for natural inflammation support, consider omega-3 supplements with DHA/EPA + curcumin (like these formulations)—they may target PGE2 more effectively than plain fish oil.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study tested two omega-3 supplements in a dish with immune cells from one person. It showed the supplements made the cells less reactive to a bacterial trigger. But it didn't test this in real people or in the body, so we can't say it will work the same way in humans.
Major conflicts — industry funding with significant control over the research. Reporting score and overall score cap have been reduced.
Strengths
- Used primary human monocytes (not cell lines)
- Standardized LPS stimulation protocol
- Dose-response testing across multiple concentrations
Weaknesses
- Single donor limits generalizability
- No randomization or blinding
- No control group beyond LPS (e.g., positive pharmacological control)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The experiment was done carefully in the lab, but using cells from just one person makes it like testing a new toy on one kid—you don't know if it'll work for everyone else. That's why we need more tests with more people before we trust it for real health advice.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
31 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1)+0.1/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an in vitro study using monocytes from a single donor, with no randomization, control group beyond LPS stimulation, or replication across individuals. It cannot establish causation in humans or rule out confounding factors.
Major COI
Major conflicts that significantly reduce study credibility
The study was conducted by authors affiliated with VivaCell Biotechnology GmbH, a company that likely produces the Omega-3-based nutraceuticals under investigation, creating a significant conflict of interest.
Funders
Conflict Details
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
Ethno-Health Group B.V.: Affiliated with a company potentially involved in the nutraceutical supply chain
VivaCell Biotechnology GmbH: Employed by the company producing the Omega-3 nutraceuticals being tested
No independent funding source or external oversight is mentioned. The entire research team is employed by entities with direct commercial interest in the product tested, raising serious concerns about bias in study design, data interpretation, and publication.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
4 researchersIf this is your work, this is how we attribute it on Fit Body Science. Thorsten Rose is listed as the lead author.
- Bernd L. FiebichCorresponding